Surgical Products - Product section.(Directory)
January 11th, 2009 ANESTHESIOLOGY
ACCESSORY PRODUCTS
Agents
Merit Pharmaceuticals, Pharmaceutical/Medical/Surgical Products, Los Angeles, CA
Regulators
Allied Healthcare Products, Inc., St. Louis, MO
Precision Medical, Inc., Northampton, PA
Responsive Respiratory Inc., St. Louis, MO
Topical
Cryopak Industries, St. Leonard, PQ Canada
Gebauer Company, Cleveland, OH
EQUIPMENT
Anesthesia Delivery Systems…
Chain Drug Review - FDA approves applications for two drugs made by GSK
January 8th, 2009GlaxoSmithKline PLC has received two significant marketing approvals from the Food and Drug Administration. Requip has been cleared as a treatment for moderate-to-severe restless legs syndrome in adults. Boostrix has been given the O.K. as the first combination vaccine to help protect adolescents against whooping cough.
Related Results
Requip for RLSRequip reduces risk of dyskine…
Chain Drug Review - Requip reduces risk of dyskinesias
January 1st, 2009A recently released study shows that early treatment with the Parkinson’s disease drug Requip significantly reduces the risk of dyskinesias, involuntary body movements that are often associated with levodopa, a popular Parkinson’s therapy. SmithKline Beecham PLC received Food and Drug Administration approval for Requip, a second-generation dopamine agonist, about two years ago.
…
Drug Store News - SKB, SkyePharma ink pact for once-daily Requip
December 31st, 2008SmithKline Beecham and SkyePharma have entered into a development and licensing agreement for a once-daily version of SKB’s anti-Parkinson’s disease drug, Requip (ropinirole), using SkyePharma’s Geomatrix oral deliv…
M2 Presswire - SMITHKLINE BEECHAM: Smithkline Beecham & SkyePharma si sign agreement to develop once daily Requip.
December 28th, 2008M2 PRESSWIRE-17 September 1999-SMITHKLINE BEECHAM: Smithkline Beecham and SkyePharma sign agreement to develop once daily Requip (C)1994-99 M2 COMMUNICATIONS LTD RDATE:150999 LONDON — SmithKline Beecham (SB) and SkyePharma PLC announced today that they have entered into a development and licensing agreement for a once-daily version of SB’s…
Clinical Psychiatry News - Drug approved for Parkinson’s
December 25th, 2008Requip XL (ropirinole extended release tablets) have been approved by the Food and Drug Administration for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. It is the first and only oral once-daily non-ergot do…
M2 Presswire - SMITHKLINE BEECHAM: Study shows early treatment with Pa Parkinson’s drug Requip reduces risk of dyskinesias.
December 19th, 2008M2 PRESSWIRE-30 July 1999-SMITHKLINE BEECHAM: New study shows early treatment with Parkinson’s drug Requip significantly reduces the risk of dyskinesias and is effective long-term (C)1994-99 M2 COMMUNICATIONS LTD RDATE:290799 Vancouver, Canada — Reports of Parkinson’s disease affecting public figures such as Janet Reno, Michael J.
Related Results
Requip for RLSRequip reduces risk of dyskinesiasRequip now has generic competitorsGSK’s Requip significantly imp…
Business Wire - Judge Appoints Legal Team for Paxil Products Liability Litigation
December 16th, 2008SkyePharma - Update on Convertible Bonds and Current Trading
LONDON, UK, 8 July, 2008 - SkyePharma PLC (LSE: SKP) today provides an
update on progress with the convertible bonds and current trading.
Progress with convertible bon…
PR Newswire - Best Practice Database Adds Research on New Product Commercialization
December 13th, 2008CHAPEL HILL, N.C., June 25 /PRNewswire/ — New research that explores the tactics and strategies that lead to successful product development, launch and management is now available in the Best Practice Database, an online research repository managed by research and consulti…
Finally, A Treatment for Restless Leg Syndrome
December 10th, 2008Most people who suffer from restless leg syndrome are tormented each night through this severe pain and leg motion. Drug companies want you to believe that they have a cure, but a simple look at the headlines will show what many restless leg sufferers are scared of:
Mirapex: “Patients taking certain medicines to treat Parkinson’s disease or RLS, including Mirapex… have reported problems wi…


